Biochemistry
-
Uddin receives Phi Beta Psi award to continue development of diagnostic tool for detecting pathological cells
By Leah Mann Research Associate Professor of Biochemistry, Md. Jashim Uddin Md. Jashim Uddin, research associate professor of biochemistry, has received a 2022 National Project Research Grant from Phi Beta Psi. Uddin was one of six recipients nationally and is the first-ever Vanderbilt faculty member to receive this… Read MoreDec. 14, 2022
-
Pietenpol named chief scientific and strategy officer
Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership role… Read MoreFeb. 10, 2022
-
Profiling chromatin accessibility and DNA methylation—simultaneously
Research led by Emily Hodges, assistant professor of biochemistry, first-author Lindsey Guerin, a graduate student in the Hodges lab, and Kelly Barnett, a recent graduate of the Hodges lab, developed and tested a new method called ATAC-Me, which profiles multiple epigenetic features, including DNA methylation, simultaneously from a single DNA… Read MoreFeb. 1, 2022
-
Meet the departments: An inward look into Biochemistry
The Department of Biochemistry is nestled within the School of Medicine Basic Sciences, but even though Basic Sciences was only established in 2015, the biochemistry department has been an integral part of Vanderbilt since its foundation in 1925. Today, the department pushes forward by focusing on hiring exceptional faculty, developing its research infrastructure, and continually improving its training environment. Read MoreJan. 6, 2022
-
Scott Hiebert, PhD awarded grant from V Foundation to support study of pediatric soft tissue sarcoma
The V Foundation for Cancer Research has awarded a $600,000 grant to Scott Hiebert, PhD, professor of Biochemistry and Medicine, to pursue a possible precision therapy for a type of sarcoma that predominantly affects children. Scott Hiebert, PhD Hiebert, the Hortense B. Ingram Professor of Cancer Research, will develop a… Read MoreOct. 29, 2021